# Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer

> **NCT07667192** · — · RECRUITING · sponsor: **Affidea Nu-med Center of Oncological DIagnostics and Therapy** · enrollment: 500 (estimated)

## Conditions studied

- Recurrent Gynecologic Cancer
- Recurrent Uterine Cancer
- Recurrent Cervical Cancer
- Recurrent Vaginal Cancer
- Recurrent Vulvar Cancer
- Recurrent Ovarian Cancer
- Recurrent Fallopian Tube Cancer
- Primary Peritoneal Cancer

## Interventions

- **RADIATION:** Reirradiation
- **OTHER:** Total Ablative Strategy

## Key facts

- **NCT ID:** NCT07667192
- **Lead sponsor:** Affidea Nu-med Center of Oncological DIagnostics and Therapy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-11
- **Primary completion:** 2031-12
- **Final completion:** 2036-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07667192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07667192, "Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07667192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*